Skip to content

Mechanism of inter-compartmental progression of osteoarthritis in patients with genu varum

Mechanism of inter-compartmental progression of osteoarthritis in patients with genu varum

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080219
Enrollment
Unknown
Registered
2024-01-24
Start date
2024-02-05
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Control group:None
Single-compartmental OA group:None
Multi-compartmental OA group:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Control group ? Patients aged 20-70 ? Patients willing to reconstruct anterior cruciate ligament (ACL) and needing to undergo inter-condyle fossa plasty ? Patients with no diagnosis of osteoarthritis which is confirmed by X-ray or MRI (Kellgren & Lawrence level <I) ? Patients consent to participate in the study, having signed the informed consent Single-compartmental OA group ? Patients aged 20-70 ? Patients diagnosed with genu varum by X-ray ? Patients with diagnosis of medial single compartmental osteoarthritis (Kellgren & Lawrence level III/IV) which is confirmed by X-ray ? Patients with severe pain, not alleviated by non-operative therapy, willing to undergo uni-compartmental or total knee arthroplasty ? Patients consent to participate in the study, having signed the informed consent Multi-compartmental OA group ? patients aged 20-70 ? Patients diagnosed with genu varum by X-ray ? Patients with diagnosis of multiple compartmental osteoarthritis (Kellgren & Lawrence level III/IV) which is confirmed by X-ray ? Patients with severe pain, not alleviated by non-operative therapy, willing to undergo total knee arthroplasty ? Patients consent to participate in the study, having signed the informed consent

Exclusion criteria

Exclusion criteria: ? Patients with psychosis or mental problem ? Patients with severe obesity (BMI>35) ? Patients diagnosed with autoimmune arthritis, gout, infectious arthritis or other types of arthritis ? Patients who are unable or unwilling to undergo rehabilitation ? Patients with severe ankylosis or knee fibrosis ? Patients with abnormal plasma/free calcium levels, severe primary CVD, lung disease, endocrinological and metabolic diseases, or other lethal disease including cancer or HIV, who are considered not suitable to be included ? Patients with other acute and chronic diseases who are considered not suitable to be included

Design outcomes

Primary

MeasureTime frame
RNA gene expression in cartilage tissue;

Countries

China

Contacts

Public ContactPeng Xiaochun; Zhao Jinzhong

Shanghai Sixth People's Hospital

zhaojinzhong@vip.163.com+86 137 0757 1526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026